New implantable biotechnology produces and releases CAR-T cells for attacking tumors

Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed an implantable biotechnology that produces and releases CAR-T cells for attacking cancerous tumors.

Related Keywords

Texas ,United States ,Yevgeny Brudno ,Pritha Agarwalla ,Frances Ligler ,Emily Henderson ,Department Of Microbiology ,University Of North Carolina At Chapel Hill ,Texasam University ,Lineberger Cancer Center ,Carolina State University ,Immunology Program ,North Carolina State University ,North Carolina ,Chapel Hill ,Multifunctional Alginate Scaffolds ,Gianpietro Dotti ,Cancer ,Antibodies ,Biotechnology ,Cancer Treatment ,Fell ,Immune System ,Mmunology ,Implants ,N Vivo ,Lymphoma ,Manufacturing ,Athogen ,Proliferation ,Research ,Herapeutics ,Virus ,